Natural trans-Crotonin: The Antiulcerogenic Effect of Another Diterpene Isolated from the Bark of Croton cajucara Benth.
-
- Hiruma-Lima Clélia Akiko
- Departamento de Fisiologia, Instituto de Biociências, Universidade Estadual Paulista
-
- Toma Walber
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Gracioso Juliano de Souza
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Almeida Ana Beatriz Albino de
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Batista Leônia Maria
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Magri Luciana
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Paula Ana Cláudia Bensuaski de
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Soares Fernanda Rocha
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
-
- Nunes Domingos Sávio
- Departamento de Química, Universidade Estadual de Ponta Grossa
-
- Brito Alba Regina Monteiro Souza
- Departamento de Fisiologia e Biofisica, Instituto de Biologia, Universidade Estadual de Campinas
この論文をさがす
説明
The nor-clerodane diterpene trans-crotonin isolated from the bark of Croton cajucara BENTH. was investigated for its ability to prevent the formation of gastric-mucosa ulceration in different experimental models in mice. The results obtained from crotonin were compared with those obtained with another diterpene, DHC (trans-dehydrocrotonin) in the same models. When previously administered (p.o.) at the dose of 100 mg/kg, crotonin, as well as DHC, significantly reduced (p<0.05) gastric injury induced by stress (72, 67%), indomethacin/bethanechol (78, 29%) and pylorus ligature (35, 30%). In the HCl/ethanol-induced gastric ulcer model, at oral doses of 100 and 250 mg/kg, crotonin significantly prevented (p<0.05) the formation of gastric lesions by 51 and 56%, respectively, when compared to the control group. Gastric injury was also of significantly less magnitude in the DHC treatment group (p<0.05). In the pylorus-ligature model, crotonin (p.o.), like cimetidine, increased the volume of gastric juice when compared to the control group (p<0.05). No significant modifications where found in gastric parameters such as pH or total acid content after oral crotonin treatment. However, systemic alterations were observed when crotonin (100 mg/kg) was previously administered intraduodenally to mice. We observed significant changes (p<0.001) in gastric-juice parameters such as an increase in volume and a decrease in gastric acidity. Those pre-treated with crotonin as well as with DHC did not increase free mucus production (p>0.05). The results suggest that crotonin presents a significant anti-ulcer effect when assessed in these ulcer-induced models. As with DHC, the antiulcerogenic effects of crotonin are probably related to anti-secretory or/and gastroprotective properties of this substance. In light of results obtained with DHC and natural trans-crotonin in the present study, we concluded that the A-ring of both diterpenes is not directly involved in the antiulcerogenic activity.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 25 (4), 452-456, 2002
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204627722240
-
- NII論文ID
- 110003638801
-
- NII書誌ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD38XkslWrs7o%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 6120693
-
- PubMed
- 11995923
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可